Navigation Links
Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
Date:4/23/2010

IRVINE, Calif., April 23 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) will announce results for the Company's fiscal third quarter of 2010 for the period ended March 31, 2010 on Thursday, April 29, 2010 after the market closes.

Following the release, Pro-Dex will conduct a conference call at 4:30 p.m. Eastern Time (1:30 Pacific Time) to discuss operating performance for the quarter.  Mark Murphy, Chief Executive Officer and Jeff Ritchey, Chief Financial Officer, plan to host the call.  If you would like to join the call, domestic callers dial (866) 317-6010 and international callers dial (412) 317-6010, conference I.D. 440155.  You can identify the call as the Pro-Dex Third Quarter Earnings Call.  The call will also be broadcast live over the internet and may be accessed directly by visiting www.videonewswire.com/event.asp?id=68584 or by visiting the Company's website at www.pro-dex.com.  

For those who cannot access the live broadcast, a replay will be available from 2 hours after the call for 48 hours by dialing (877) 344-7529 for domestic callers or (412) 317-0088 for international calle
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
2. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
3. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
4. pHase Pharmaceuticals Announces New Venture
5. Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations
6. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
7. Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding
8. Codexis, Inc. Announces Pricing of Initial Public Offering
9. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
10. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
11. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 ... of the "Global Ablation Technologies (Radiofrequency, Ultrasound, ... 2019" report to their offering. ... the global ablation technologies market has been divided ... ultrasound, microwave, cryotherapy, hydrothermal, and hydromechanical ablation technologies. ...
(Date:9/22/2014)... - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), ... marijuana products, is pleased to announce that its wholly ... definitive lease agreement for a second facility located in ... 28,966 square feet of floor space with the option ... for a total of approximately 43,500 square feet. ...
(Date:9/22/2014)... Pa. , Sept. 22, 2014  Olympus, ... innovative solutions for medical and surgical procedures, among ... a deal with Munich -based ... Kick ® Navigation. This agreement applies to ... for cross-disciplinary U.S. sales and all distribution outside ...
Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... 26 New Health Sciences Inc. (NHSi) has ... National Heart, Lung and Blood Institute of the National ... system. The project aims to develop the Hemanext ... transfusion therapy and extends the shelf life of blood ...
... ("Senesco" or the "Company") (NYSE Amex: SNT ) ... conducted in Dr. William Scheld,s lab at the University of ... against Senesco,s Factor 5A gene had a 52% survival rate as ... treatment or a control siRNA.A total of 73 mice were infected ...
Cached Medicine Technology:Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3Senesco Announces H1N1 Influenza Survival Test Results in Mice 2Senesco Announces H1N1 Influenza Survival Test Results in Mice 3
(Date:9/22/2014)... ARBOR, Mich. A surprising new study pulls back ... in health care: differences in payment and income between ... who don,t. , Contrary to perception, the research ... to favor surgeons and other procedure-performing doctors. , The ... simple difference in pay per minute explains why doctors ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... parents are aware of online physician-rating sites, and more than ... children, according to a new national study. The findings ... further suggest that negative online ratings may dissuade parents from ... by a neighbor. Conversely, a positive online rating may ...
(Date:9/22/2014)... (September 22, 2014) South Asians living in Canada ... the rate of diabetes compared with while people, McMaster ... today in the Canadian Medical Association Journal (CMAJ ... , One of the fastest-growing ethnic groups in ... Asian people living in Canada, comprising about three percent ...
(Date:9/22/2014)... September 22, 2014. Kessler researchers have published a ... psychoeducational wellness program in people with multiple sclerosis ... mental health, perceived stress, and pain. "Development ... individuals living with MS: Description and outcomes" was ... the International Journal of MS Care ...
(Date:9/22/2014)... Two new prescription devices approved by the U.S. Food ... people with migraine headaches who don,t tolerate migraine medications ... -- the Cefaly -- is designed to prevent migraines, ... meant to be used when migraines first start, according ... looking for alternative migraine treatments. Because these devices aren,t ...
Breaking Medicine News(10 mins):Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2
... Massachusetts Medical School have uncovered a novel DNA-sensing pathway ... for malaria. Activation of this pathway appears to stimulate ... immune system that may contribute to inflammation and fever ... susceptibility for the most common and lethal form of ...
... Calif.) The possibility of developing stem cells from ... conditions as diverse as Parkinson,s disease, Alzheimer,s disease and ... research community in recent years. Such therapies would avoid ... human embryos, and in theory, also bypass immunological problems ...
... heart contains cardiac stem cells that can contribute to regeneration ... about the molecules and pathways that regulate these cells. Now, ... insight into one way to coax the cardiac stem cells ... Press in the August 2011 issue of the journal ...
... Companies like Google and Zappos.com are famous for ... environments, but are their employees healthier too? According to ... your co-workers has long-term health benefits. Dr. ... TAU,s Leon Recanati Graduate School of Business Administration says ...
... Denise Mann HealthDay Reporter , THURSDAY, Aug. 4 ... harnessing the power of stem cells to help treat, and ... in a recent issue of the Journal of the ... be reprogrammed to morph into other types of kidney cells ...
... Medical Sciences of the National Institutes of Health (NIH) ... million to support the Wayne State University Initiative for ... established in 1978 as the Minority Biomedical Research Support ... graduate students with a more personalized experience to foster ...
Cached Medicine News:Health News:Targeting innate immunity in malaria 2Health News:Targeting innate immunity in malaria 3Health News:A patient's own skin cells may one day treat multiple diseases 2Health News:A patient's own skin cells may one day treat multiple diseases 3Health News:Hormone reduces risk of heart failure from chemotherapy 2Health News:Hang out at the water cooler, live longer 2Health News:Hang out at the water cooler, live longer 3Health News:Stem Cell Therapy Holds Promise for Kidney Disease 2Health News:Stem Cell Therapy Holds Promise for Kidney Disease 3Health News:Wayne State University awarded $3 million from NIH to foster science and research careers 2Health News:Wayne State University awarded $3 million from NIH to foster science and research careers 3
Rotating 360 degrees, 3 mm x 7 mm bite....
45 degree, forward 3 mm, 4 mm x 5 mm cup, length of shaft 140 mm, overall length 8.3 inches....
20 mm. Plastic, methylmethacrylate. Supplied sterile....
Small right. Teflon orbital plates....
Medicine Products: